CARsgen Therapeutics hits nearly 11-week high on share buyback plan
** CARsgen Therapeutics Holdings 2171.HK jumps 13.7% to HK$18.88, highest since February 27 ** Stock set for biggest one-day pct rise since April 22 ** Chinese cell therapies developer to repurchase shares representing up to 1% of the total issued shares in the open market within 150 Hong Kong trading days from May 8 ** Co says repurchase will be funded through non-IPO raised funds, including business development income, interest income and other subsidy ** YTD, stock up 104.1% (Reporting by Donny Kwok) ((donny.kwok@thomsonreuters.com))
Recent news on CARsgen Therapeutics Holdings
See all newsBrief: Carsgen Therapeutics Says CT1190B Receives IND Clearance From NMPA For Relapsed/Refractory Large B-Cell Lymphoma
Brief: Carsgen Therapeutics Says CT0596 Receives IND Clearance From NMPA
Brief: Carsgen Therapeutics Approves Share Repurchase Plan For Up To 30.12 Million Shares
CARsgen Therapeutics climbs on board nod for share buyback
Brief: Carsgen Therapeutics Says NMPA Approves Satricabtagene Autoleucel For Advanced Gastric Cancer